drugset / Trial / NCT07652216

Bone Defects Reconstruction After Dentigerous Cyst Enucleation With Autogenous Demineralized Dentin Matrix- ADDM and Advanced Platelet-Rich Fibrin- A-PRF.

NCT07652216

Active not recruiting 35 enrolled Jagiellonian University
RandomizedParallel-groupOpen-labelTreatment

Summary

This prospective clinical study evaluates bone healing following dentigerous cyst enucleation associated with impacted mandibular third molar extraction. The study compares spontaneous blood clot healing, Advanced Platelet-Rich fibrin (A-PRF), and A-PRF combined with Autogenous Dentin Demineralized Matrix (ADDM). Bone healing is assessed as the primary outcome, while postoperative pain intensity assessed using the Numerical Rating Scale (NRS) with graphical representation represents a secondary outcome. The study aims to determine whether the use of A-PRF or A-PRF combined with ADDM improves postoperative healing outcomes compared with spontaneous blood clot healing.

Timeline

Start
2024-04-04
Primary completion
2026-12-01
Completion
2027-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Advanced Platelet Rich Fibrin Other / unclassified
Subject Autogenous Demineralized Dentin Matrix Other / unclassified